Skip to Content

OGT 918 100 (Zavesca 100 mg)

Generic Name: miglustat

Pill with imprint OGT 918 100 is White, Capsule-shape and has been identified as Zavesca 100 mg. It is supplied by Actelion Pharmaceuticals US Inc.

Zavesca is used in the treatment of gaucher disease and belongs to the drug class miscellaneous metabolic agents. Risk cannot be ruled out during pregnancy. Zavesca 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for OGT 918 100

Zavesca 100 mg OGT 918 100

Zavesca

Generic Name
miglustat
Imprint
OGT 918 100
Strength
100 mg
Color
White
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Miscellaneous metabolic agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actelion Pharmaceuticals US Inc
National Drug Code (NDC)
66215-0201
Inactive Ingredients
sodium starch glycolate type A potato, povidone k30, magnesium stearate, titanium dioxide, ferrosoferric oxide, shellac

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "OGT 918 100"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.